Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Flexibly Dosed Paliperidone Extended Release (ER) for schizophrenia.
In BelgiumThis study is ongoing in France, in Belgium, in Czechia, .... It focuses on schizophrenia.
In Belgium
This study is completed in the United Kingdom, in Belgium, in Germany, .... It is testing intranasal Esketamine for treatment-resistant depression.
In Belgium
This study is ongoing in France, in Belgium, in Sweden, .... It is testing aticaprant for depression.
In BelgiumThis study is completed. It focuses on mental health and currently lists study information in Belgium, Germany, Spain, and the United Kingdom.
Remote / onlineThis study is active but not recruiting. It focuses on depression and currently lists study information in Belgium.
In BelgiumThis study is enrolling by invitation. It focuses on depression and currently lists participation information in Belgium.
In BelgiumThis study is completed. It focuses on ADHD and currently lists study information in Belgium, Canada, Germany, Hungary, Italy, Poland, Spain, Sweden, the United Kingdom, and the United States.
In BelgiumThis study is completed. It focuses on schizophrenia and currently lists study information in Argentina, Austria, Belgium, Brazil, Bulgaria, China, Czech Republic, Denmark, Finland, Germany, Lithuania, Mexico, Portugal, Serbia, South Korea, Taiwan, the United Kingdom, and the United States.
In BelgiumThis study is completed. It focuses on anxiety and currently lists study information in Belgium.
In BelgiumThis study is completed in the United States, in France, in the United Kingdom, .... It is testing LDX for ADHD.
In BelgiumThis study is completed. It focuses on ADHD and currently lists study information in Belgium.
In BelgiumHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.